| 8.3 |
24.8 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 6.9 |
27.7 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 6.3 |
37.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 5.1 |
15.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 5.0 |
19.8 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 4.5 |
13.5 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 4.5 |
13.5 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 4.4 |
17.8 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 4.3 |
4.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 4.2 |
25.2 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 4.1 |
12.3 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 4.1 |
32.8 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 4.1 |
12.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 4.1 |
12.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 4.0 |
23.9 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 3.9 |
11.6 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 3.8 |
19.2 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 3.8 |
11.5 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 3.8 |
15.2 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 3.7 |
14.7 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 3.6 |
7.2 |
GO:1990035 |
calcium ion import into cell(GO:1990035) |
| 3.6 |
10.8 |
GO:2000043 |
regulation of cardiac cell fate specification(GO:2000043) |
| 3.6 |
10.7 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 3.5 |
7.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 3.5 |
14.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 3.5 |
69.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 3.4 |
6.8 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 3.3 |
13.1 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 3.3 |
26.3 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 3.3 |
9.8 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 3.2 |
9.7 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 3.2 |
19.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 3.2 |
12.8 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 3.2 |
16.0 |
GO:0071038 |
nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 3.2 |
22.3 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 3.2 |
9.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 3.2 |
9.5 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 3.1 |
9.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 3.0 |
9.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 3.0 |
9.0 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 3.0 |
3.0 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 2.9 |
20.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 2.8 |
8.4 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 2.8 |
8.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 2.8 |
11.1 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 2.8 |
8.3 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 2.7 |
38.3 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 2.7 |
16.1 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 2.6 |
2.6 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 2.5 |
12.6 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 2.5 |
17.4 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 2.5 |
2.5 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 2.4 |
9.7 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 2.4 |
2.4 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 2.4 |
9.7 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 2.4 |
7.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 2.4 |
9.5 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 2.4 |
2.4 |
GO:0043366 |
beta selection(GO:0043366) |
| 2.4 |
7.1 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 2.3 |
86.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 2.3 |
7.0 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.3 |
16.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 2.3 |
6.9 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 2.3 |
11.4 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 2.3 |
25.0 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 2.3 |
6.8 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 2.2 |
9.0 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 2.2 |
8.9 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 2.2 |
2.2 |
GO:0072095 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 2.2 |
2.2 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 2.2 |
58.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 2.2 |
6.5 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 2.2 |
28.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 2.1 |
17.2 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 2.1 |
6.4 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 2.1 |
4.2 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 2.1 |
6.3 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 2.1 |
6.3 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 2.1 |
8.4 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 2.1 |
10.4 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 2.1 |
76.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 2.1 |
12.4 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 2.0 |
6.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 2.0 |
12.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 2.0 |
10.1 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 2.0 |
12.2 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 2.0 |
8.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 2.0 |
6.1 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 2.0 |
6.0 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 2.0 |
6.0 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 2.0 |
8.0 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 2.0 |
10.0 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 2.0 |
6.0 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.9 |
9.7 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 1.9 |
3.8 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 1.9 |
5.8 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 1.9 |
7.5 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 1.9 |
16.8 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.9 |
7.4 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 1.8 |
5.5 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 1.8 |
5.5 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.8 |
11.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 1.8 |
1.8 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 1.8 |
9.1 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 1.8 |
14.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.8 |
9.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.8 |
25.2 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 1.8 |
5.4 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 1.8 |
8.9 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 1.8 |
5.3 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 1.7 |
5.2 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.7 |
3.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 1.7 |
5.2 |
GO:0045472 |
response to ether(GO:0045472) |
| 1.7 |
29.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 1.7 |
12.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 1.7 |
1.7 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 1.7 |
15.4 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 1.7 |
18.7 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 1.7 |
8.5 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 1.7 |
1.7 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 1.7 |
11.8 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 1.7 |
3.4 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.7 |
16.7 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 1.7 |
1.7 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.7 |
9.9 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 1.6 |
4.9 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 1.6 |
6.5 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 1.6 |
4.9 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 1.6 |
6.5 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 1.6 |
4.9 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 1.6 |
1.6 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 1.6 |
1.6 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 1.6 |
21.0 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.6 |
3.2 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 1.6 |
4.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.6 |
8.0 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.6 |
4.8 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.6 |
6.4 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 1.6 |
19.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 1.6 |
27.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 1.6 |
3.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 1.6 |
4.7 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 1.6 |
4.7 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 1.6 |
1.6 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 1.5 |
13.9 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 1.5 |
6.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.5 |
3.0 |
GO:0001839 |
neural plate morphogenesis(GO:0001839) |
| 1.5 |
10.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.5 |
9.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 1.5 |
12.1 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 1.5 |
10.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 1.5 |
4.5 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.5 |
3.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.5 |
7.4 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 1.5 |
11.8 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 1.5 |
7.4 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 1.5 |
2.9 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) nephric duct formation(GO:0072179) |
| 1.5 |
4.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 1.5 |
7.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 1.5 |
5.8 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 1.5 |
49.6 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 1.5 |
7.3 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 1.5 |
2.9 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 1.4 |
2.9 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 1.4 |
35.9 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 1.4 |
7.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 1.4 |
1.4 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 1.4 |
1.4 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.4 |
4.2 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.4 |
12.7 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.4 |
12.6 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 1.4 |
4.2 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.4 |
5.6 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 1.4 |
8.3 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 1.4 |
6.9 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.4 |
5.5 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 1.4 |
6.8 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 1.4 |
4.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 1.4 |
9.5 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 1.4 |
4.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.3 |
4.0 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 1.3 |
5.4 |
GO:0034135 |
regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
| 1.3 |
21.5 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 1.3 |
9.4 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 1.3 |
2.7 |
GO:0045738 |
negative regulation of DNA repair(GO:0045738) |
| 1.3 |
44.2 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 1.3 |
4.0 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.3 |
51.7 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 1.3 |
4.0 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 1.3 |
1.3 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 1.3 |
9.2 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.3 |
3.9 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 1.3 |
9.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 1.3 |
22.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 1.3 |
3.9 |
GO:0003223 |
ventricular compact myocardium morphogenesis(GO:0003223) |
| 1.3 |
5.1 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 1.3 |
2.6 |
GO:0014045 |
establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
| 1.3 |
5.1 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 1.3 |
6.3 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 1.3 |
6.3 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 1.2 |
3.7 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 1.2 |
5.0 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 1.2 |
12.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 1.2 |
7.5 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 1.2 |
3.7 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.2 |
6.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 1.2 |
1.2 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 1.2 |
7.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 1.2 |
1.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 1.2 |
22.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 1.2 |
3.7 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 1.2 |
6.1 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 1.2 |
12.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 1.2 |
4.9 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 1.2 |
3.6 |
GO:0000237 |
leptotene(GO:0000237) |
| 1.2 |
1.2 |
GO:0046386 |
deoxyribose phosphate catabolic process(GO:0046386) |
| 1.2 |
13.2 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 1.2 |
4.8 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 1.2 |
9.6 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 1.2 |
1.2 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 1.2 |
24.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 1.2 |
5.9 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 1.2 |
4.7 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.2 |
3.5 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 1.2 |
7.0 |
GO:0070203 |
regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) |
| 1.2 |
5.8 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 1.2 |
1.2 |
GO:0061045 |
negative regulation of wound healing(GO:0061045) |
| 1.2 |
27.8 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 1.2 |
1.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 1.1 |
3.4 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 1.1 |
2.3 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.1 |
6.8 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 1.1 |
3.4 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 1.1 |
48.4 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 1.1 |
6.7 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 1.1 |
7.8 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 1.1 |
2.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 1.1 |
3.3 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 1.1 |
3.3 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 1.1 |
5.5 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 1.1 |
4.4 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 1.1 |
101.5 |
GO:0006413 |
translational initiation(GO:0006413) |
| 1.1 |
6.6 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 1.1 |
3.3 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 1.1 |
11.0 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 1.1 |
12.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 1.1 |
9.8 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 1.1 |
2.2 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.1 |
4.3 |
GO:0050904 |
diapedesis(GO:0050904) |
| 1.1 |
3.2 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 1.1 |
3.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 1.1 |
3.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 1.1 |
24.6 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 1.1 |
21.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 1.1 |
3.2 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 1.1 |
5.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 1.0 |
5.2 |
GO:0015867 |
ATP transport(GO:0015867) |
| 1.0 |
2.1 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 1.0 |
11.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 1.0 |
4.2 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 1.0 |
26.0 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 1.0 |
3.1 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 1.0 |
8.3 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 1.0 |
10.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 1.0 |
7.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 1.0 |
3.1 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 1.0 |
1.0 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 1.0 |
6.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.0 |
7.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 1.0 |
7.1 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 1.0 |
6.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.0 |
3.0 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 1.0 |
16.9 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 1.0 |
4.0 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 1.0 |
6.0 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 1.0 |
24.9 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 1.0 |
6.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 1.0 |
2.0 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.0 |
3.0 |
GO:1904872 |
RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 1.0 |
5.9 |
GO:0001821 |
histamine secretion(GO:0001821) |
| 1.0 |
6.9 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 1.0 |
28.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 1.0 |
7.9 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 1.0 |
7.9 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.0 |
6.9 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 1.0 |
10.8 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 1.0 |
3.9 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 1.0 |
3.9 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 1.0 |
7.8 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 1.0 |
2.9 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 1.0 |
3.8 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 1.0 |
4.8 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.9 |
5.7 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.9 |
7.5 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.9 |
5.6 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.9 |
10.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.9 |
2.8 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.9 |
2.8 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.9 |
2.8 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.9 |
3.7 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.9 |
1.8 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.9 |
3.7 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.9 |
2.8 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.9 |
0.9 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.9 |
2.7 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.9 |
2.7 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.9 |
6.3 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.9 |
7.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.9 |
0.9 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.9 |
3.6 |
GO:0071281 |
cellular response to iron ion(GO:0071281) |
| 0.9 |
1.8 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.9 |
2.7 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.9 |
2.7 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.9 |
8.9 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.9 |
9.7 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.9 |
3.5 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.9 |
7.9 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.9 |
5.2 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.9 |
1.7 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.9 |
7.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.9 |
2.6 |
GO:0060998 |
regulation of dendritic spine development(GO:0060998) |
| 0.9 |
3.5 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.9 |
11.3 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.9 |
12.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.9 |
5.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.9 |
5.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.9 |
2.6 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.9 |
3.4 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.9 |
5.1 |
GO:0000959 |
mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
| 0.9 |
1.7 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.9 |
2.6 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.8 |
5.9 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.8 |
3.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.8 |
3.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 |
3.4 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.8 |
1.7 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.8 |
2.5 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.8 |
1.7 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.8 |
0.8 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) negative regulation of chromatin binding(GO:0035562) |
| 0.8 |
7.5 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.8 |
14.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.8 |
1.7 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.8 |
1.7 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.8 |
3.3 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.8 |
19.8 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.8 |
5.7 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.8 |
2.5 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.8 |
3.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.8 |
2.4 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.8 |
7.3 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.8 |
8.9 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.8 |
0.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.8 |
5.6 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.8 |
10.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.8 |
4.0 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.8 |
2.4 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.8 |
0.8 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.8 |
2.4 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.8 |
14.9 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.8 |
3.1 |
GO:0046618 |
drug export(GO:0046618) |
| 0.8 |
1.6 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.8 |
1.5 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.8 |
4.6 |
GO:0032816 |
positive regulation of natural killer cell activation(GO:0032816) |
| 0.8 |
2.3 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.8 |
0.8 |
GO:0035878 |
nail development(GO:0035878) |
| 0.8 |
1.5 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.8 |
6.2 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.8 |
0.8 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.8 |
2.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.8 |
2.3 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.8 |
261.9 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.8 |
2.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.7 |
2.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.7 |
2.2 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.7 |
3.0 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.7 |
2.9 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.7 |
2.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.7 |
4.4 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.7 |
3.6 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.7 |
3.6 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.7 |
2.2 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.7 |
11.6 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.7 |
2.2 |
GO:0060021 |
palate development(GO:0060021) |
| 0.7 |
2.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.7 |
6.5 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.7 |
3.6 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.7 |
3.6 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.7 |
2.1 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.7 |
1.4 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.7 |
5.7 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.7 |
4.9 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.7 |
2.1 |
GO:1902031 |
regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.7 |
1.4 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.7 |
0.7 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.7 |
1.4 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.7 |
1.4 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.7 |
2.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.7 |
1.4 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.7 |
7.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.7 |
23.8 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.7 |
4.1 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.7 |
6.8 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.7 |
17.6 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.7 |
2.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.7 |
2.0 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.7 |
2.7 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.7 |
0.7 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.7 |
1.3 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.7 |
4.0 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.7 |
7.9 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.7 |
2.6 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.7 |
2.0 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.7 |
2.0 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.6 |
13.0 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.6 |
9.0 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.6 |
3.8 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.6 |
3.8 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.6 |
1.3 |
GO:1902866 |
regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
| 0.6 |
2.5 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.6 |
1.3 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.6 |
1.9 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.6 |
2.5 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.6 |
4.4 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.6 |
0.6 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.6 |
3.1 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.6 |
3.7 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.6 |
0.6 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.6 |
13.0 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.6 |
2.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.6 |
4.9 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.6 |
3.7 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.6 |
1.8 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.6 |
1.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.6 |
0.6 |
GO:0070555 |
response to interleukin-1(GO:0070555) |
| 0.6 |
20.2 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.6 |
4.3 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.6 |
6.7 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.6 |
3.7 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.6 |
4.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.6 |
0.6 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.6 |
0.6 |
GO:0071426 |
ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.6 |
6.0 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.6 |
1.8 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.6 |
6.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.6 |
0.6 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.6 |
2.4 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.6 |
4.8 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.6 |
38.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.6 |
4.2 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.6 |
4.7 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.6 |
2.9 |
GO:1903671 |
negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.6 |
2.9 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.6 |
2.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.6 |
2.9 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.6 |
0.6 |
GO:0002374 |
cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) |
| 0.6 |
4.1 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.6 |
1.2 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.6 |
2.9 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.6 |
6.3 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.6 |
1.7 |
GO:1904357 |
negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.6 |
5.1 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.6 |
0.6 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.6 |
1.1 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.6 |
5.1 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.6 |
0.6 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.6 |
3.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.6 |
7.8 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.6 |
2.2 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.6 |
1.7 |
GO:0003149 |
membranous septum morphogenesis(GO:0003149) |
| 0.5 |
2.7 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.5 |
31.6 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.5 |
1.6 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.5 |
3.8 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.5 |
2.2 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.5 |
13.0 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.5 |
1.6 |
GO:1900103 |
positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.5 |
11.3 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.5 |
1.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 |
0.5 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.5 |
0.5 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.5 |
1.1 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.5 |
1.6 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.5 |
0.5 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.5 |
1.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.5 |
1.6 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.5 |
0.5 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.5 |
2.6 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.5 |
4.2 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.5 |
3.1 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.5 |
6.8 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.5 |
10.9 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.5 |
0.5 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.5 |
2.6 |
GO:0070170 |
regulation of tooth mineralization(GO:0070170) |
| 0.5 |
1.0 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.5 |
1.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.5 |
4.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.5 |
4.0 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.5 |
1.0 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.5 |
2.0 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.5 |
3.5 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.5 |
1.0 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 0.5 |
1.0 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.5 |
2.0 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.5 |
1.0 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.5 |
4.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 |
2.0 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.5 |
1.0 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.5 |
1.5 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.5 |
4.4 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.5 |
14.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.5 |
5.4 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.5 |
2.0 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.5 |
1.5 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.5 |
1.5 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.5 |
1.5 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 |
4.3 |
GO:0033045 |
regulation of sister chromatid segregation(GO:0033045) |
| 0.5 |
4.3 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.5 |
10.1 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.5 |
2.4 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.5 |
1.4 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.5 |
14.9 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.5 |
3.4 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.5 |
5.7 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.5 |
1.9 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.5 |
4.7 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.5 |
3.3 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.5 |
0.9 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.5 |
2.3 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
| 0.5 |
3.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
0.9 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.5 |
0.5 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.5 |
0.9 |
GO:0003284 |
septum primum development(GO:0003284) cell communication by chemical coupling(GO:0010643) |
| 0.5 |
2.3 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.5 |
0.9 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 |
0.9 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.5 |
1.4 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.5 |
7.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.5 |
2.8 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.5 |
2.8 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.5 |
0.9 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.5 |
1.8 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.5 |
1.8 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.4 |
2.2 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) |
| 0.4 |
34.5 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.4 |
12.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.4 |
1.3 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.4 |
1.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 |
1.8 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.4 |
2.2 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.4 |
1.3 |
GO:0071104 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) response to interleukin-9(GO:0071104) |
| 0.4 |
6.2 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.4 |
1.8 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.4 |
1.3 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.4 |
2.2 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 |
1.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.4 |
1.3 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.4 |
1.7 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.4 |
0.4 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.4 |
1.3 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.4 |
0.8 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.4 |
1.3 |
GO:0007320 |
insemination(GO:0007320) |
| 0.4 |
2.9 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 |
1.7 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.4 |
2.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 |
1.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.4 |
0.8 |
GO:0045931 |
positive regulation of mitotic cell cycle(GO:0045931) |
| 0.4 |
1.2 |
GO:0048241 |
epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.4 |
1.2 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.4 |
0.4 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.4 |
1.2 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.4 |
3.2 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.4 |
1.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
2.0 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.4 |
0.4 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 |
1.2 |
GO:0060217 |
positive regulation of chromatin assembly or disassembly(GO:0045799) hemangioblast cell differentiation(GO:0060217) |
| 0.4 |
0.4 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.4 |
1.2 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.4 |
1.2 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
0.8 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.4 |
5.6 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.4 |
0.4 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) regulation of antigen processing and presentation of peptide antigen(GO:0002583) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
| 0.4 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 |
1.2 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.4 |
0.4 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.4 |
0.8 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.4 |
2.0 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.4 |
0.4 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.4 |
2.7 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.4 |
5.5 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.4 |
0.4 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.4 |
2.3 |
GO:0044818 |
mitotic G2/M transition checkpoint(GO:0044818) |
| 0.4 |
0.4 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.4 |
1.9 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.4 |
1.5 |
GO:0015786 |
UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.4 |
0.4 |
GO:0045911 |
positive regulation of DNA recombination(GO:0045911) |
| 0.4 |
3.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.4 |
6.8 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.4 |
2.3 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.4 |
0.4 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.4 |
1.1 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.4 |
0.4 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.4 |
0.7 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.4 |
0.4 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.4 |
1.9 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.4 |
2.2 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.4 |
7.0 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.4 |
0.4 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 |
2.2 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.4 |
2.9 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.4 |
0.4 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.4 |
1.1 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.4 |
16.8 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.4 |
1.8 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.4 |
2.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.4 |
0.7 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.4 |
0.7 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.4 |
1.8 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.4 |
1.8 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.4 |
1.8 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.4 |
3.9 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.4 |
1.1 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.4 |
3.5 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.4 |
1.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 |
10.2 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.3 |
4.5 |
GO:1901343 |
negative regulation of vasculature development(GO:1901343) |
| 0.3 |
1.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.3 |
1.0 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
0.3 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.3 |
1.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 |
1.4 |
GO:0043628 |
ncRNA 3'-end processing(GO:0043628) |
| 0.3 |
1.0 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 |
4.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.3 |
0.7 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.3 |
8.4 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.3 |
2.0 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.3 |
1.0 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.3 |
4.3 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.3 |
0.7 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
3.0 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.3 |
2.0 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.3 |
2.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
1.6 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.3 |
2.6 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.3 |
1.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 |
1.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 |
2.6 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.3 |
1.9 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.3 |
0.6 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.3 |
1.3 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.3 |
2.6 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.3 |
1.0 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
0.6 |
GO:0009838 |
abscission(GO:0009838) |
| 0.3 |
1.0 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.3 |
2.2 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.3 |
8.1 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.3 |
3.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.3 |
0.6 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 |
0.9 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.3 |
0.6 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.3 |
1.8 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.3 |
0.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 |
0.9 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.3 |
1.2 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.3 |
0.9 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.3 |
1.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 |
1.8 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.3 |
0.6 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.3 |
3.6 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.3 |
0.3 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.3 |
1.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.3 |
0.6 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.3 |
1.8 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 |
1.2 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
| 0.3 |
7.1 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.3 |
12.7 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.3 |
0.6 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 |
1.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 |
0.6 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.3 |
0.3 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.3 |
8.7 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.3 |
25.9 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.3 |
3.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.3 |
2.0 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.3 |
5.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.3 |
0.9 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.3 |
3.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.3 |
7.1 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.3 |
6.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 |
6.2 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.3 |
70.6 |
GO:0006412 |
translation(GO:0006412) |
| 0.3 |
1.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.3 |
1.1 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.3 |
0.3 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.3 |
5.7 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.3 |
5.4 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.3 |
0.3 |
GO:1902679 |
negative regulation of RNA biosynthetic process(GO:1902679) |
| 0.3 |
2.1 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.3 |
9.4 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.3 |
1.3 |
GO:0001909 |
leukocyte mediated cytotoxicity(GO:0001909) |
| 0.3 |
0.5 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.3 |
2.6 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.3 |
0.8 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.3 |
2.6 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.3 |
0.5 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
0.8 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.3 |
1.3 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.3 |
1.3 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.3 |
2.9 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.3 |
0.8 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.3 |
1.8 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.3 |
2.6 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.3 |
1.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.3 |
1.0 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 |
0.8 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.3 |
7.3 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.3 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
1.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.2 |
0.2 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.2 |
1.7 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.2 |
0.5 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
1.7 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 |
3.2 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
0.5 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.2 |
0.5 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
0.5 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
4.1 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.2 |
2.4 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.2 |
1.0 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.2 |
11.9 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.2 |
1.2 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 |
1.6 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.2 |
1.6 |
GO:0010596 |
negative regulation of endothelial cell migration(GO:0010596) |
| 0.2 |
0.2 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
0.9 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 |
0.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 |
2.5 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.2 |
0.7 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 |
0.7 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 |
0.4 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 |
0.4 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
2.6 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.2 |
1.8 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 |
0.2 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.2 |
1.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.2 |
0.9 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 |
3.5 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
3.1 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.2 |
0.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
2.8 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.2 |
1.1 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.2 |
0.9 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.2 |
0.2 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.2 |
1.1 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.2 |
1.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
4.2 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.2 |
0.4 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
0.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
2.7 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.2 |
0.2 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
0.4 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.2 |
0.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.8 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.2 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
1.4 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.2 |
1.6 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
1.4 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
1.8 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.2 |
0.8 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.2 |
0.4 |
GO:0060192 |
negative regulation of lipase activity(GO:0060192) |
| 0.2 |
0.4 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.2 |
2.0 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 |
2.8 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.2 |
1.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.2 |
4.7 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.2 |
2.9 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.2 |
1.9 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.2 |
1.2 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
0.4 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.2 |
7.5 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.2 |
3.6 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 |
0.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.2 |
1.1 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.2 |
0.9 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.2 |
0.6 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) |
| 0.2 |
3.8 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.2 |
1.1 |
GO:1902745 |
positive regulation of lamellipodium organization(GO:1902745) |
| 0.2 |
1.1 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 |
4.6 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.2 |
2.8 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.2 |
0.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
1.1 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.2 |
0.7 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.2 |
0.5 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.2 |
6.7 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.2 |
0.7 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.5 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
8.3 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.2 |
1.6 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.2 |
0.9 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.2 |
0.9 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.2 |
18.5 |
GO:0044772 |
mitotic cell cycle phase transition(GO:0044772) |
| 0.2 |
1.2 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.2 |
0.9 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 |
0.2 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 |
0.5 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.2 |
1.0 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
0.2 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.2 |
0.5 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.2 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.2 |
0.3 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.2 |
0.3 |
GO:0032735 |
positive regulation of interleukin-12 production(GO:0032735) |
| 0.2 |
1.8 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.2 |
1.3 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.2 |
1.3 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.2 |
0.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 |
1.2 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.2 |
4.1 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.2 |
2.1 |
GO:0006744 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.2 |
0.8 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
0.6 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.2 |
3.9 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.3 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 |
1.3 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.2 |
1.3 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.2 |
1.6 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 |
0.5 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 |
0.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
1.7 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.2 |
1.7 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
0.8 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
0.6 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.2 |
6.0 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.2 |
1.2 |
GO:0061470 |
interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
| 0.2 |
1.1 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.9 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.1 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.1 |
0.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.7 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.6 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
1.5 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.1 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.1 |
1.6 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.1 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.5 |
GO:1900015 |
regulation of cytokine production involved in inflammatory response(GO:1900015) |
| 0.1 |
0.5 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
2.8 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
0.7 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.4 |
GO:1902742 |
apoptotic process involved in development(GO:1902742) |
| 0.1 |
1.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.4 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
3.7 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
1.3 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.5 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
1.0 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.1 |
1.7 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.1 |
0.8 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.4 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
1.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.9 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.0 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
1.1 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.5 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 |
0.7 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
1.0 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
2.0 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
1.6 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 |
0.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.7 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.5 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.1 |
0.3 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 |
4.6 |
GO:0006399 |
tRNA metabolic process(GO:0006399) |
| 0.1 |
0.7 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.8 |
GO:0071971 |
extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
1.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.4 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.1 |
3.6 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.1 |
1.1 |
GO:0046660 |
female sex differentiation(GO:0046660) |
| 0.1 |
0.9 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 |
0.4 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.5 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 |
0.8 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
2.5 |
GO:0035306 |
positive regulation of dephosphorylation(GO:0035306) |
| 0.1 |
1.2 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.3 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.5 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 |
1.7 |
GO:0010631 |
epithelial cell migration(GO:0010631) |
| 0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
1.2 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
1.1 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.9 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.8 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.1 |
0.6 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
0.7 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.5 |
GO:0046189 |
phenol-containing compound biosynthetic process(GO:0046189) |
| 0.1 |
2.5 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.4 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
2.3 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
0.5 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 |
0.5 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.5 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.1 |
1.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.3 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.2 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.1 |
0.2 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
1.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
1.9 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 0.1 |
0.4 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.6 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.1 |
2.3 |
GO:0060348 |
bone development(GO:0060348) |
| 0.1 |
0.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
1.6 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 |
1.2 |
GO:0006997 |
nucleus organization(GO:0006997) |
| 0.1 |
1.1 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.1 |
0.5 |
GO:0048659 |
smooth muscle cell proliferation(GO:0048659) |
| 0.1 |
0.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
2.6 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
2.5 |
GO:1902593 |
protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
| 0.1 |
0.3 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
1.4 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.1 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.4 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.4 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.1 |
0.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.5 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
0.3 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.3 |
GO:0070723 |
response to cholesterol(GO:0070723) |
| 0.1 |
0.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.2 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
0.5 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
0.3 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
0.4 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
0.1 |
GO:0044839 |
cell cycle G2/M phase transition(GO:0044839) |
| 0.1 |
0.1 |
GO:0060993 |
kidney morphogenesis(GO:0060993) |
| 0.1 |
0.1 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.1 |
0.4 |
GO:0006360 |
transcription from RNA polymerase I promoter(GO:0006360) |
| 0.1 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.6 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.2 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
0.1 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 |
6.0 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
0.2 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.2 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.1 |
0.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.2 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.1 |
0.5 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.2 |
GO:0003229 |
ventricular cardiac muscle tissue development(GO:0003229) ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 |
0.2 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.5 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.2 |
GO:2000258 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.1 |
0.4 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.5 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.2 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.0 |
0.7 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.0 |
0.4 |
GO:0061515 |
myeloid cell development(GO:0061515) |
| 0.0 |
0.1 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 |
0.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.5 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.4 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.0 |
0.1 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.4 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.5 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
1.0 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.3 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.2 |
GO:0098781 |
ncRNA transcription(GO:0098781) |
| 0.0 |
0.7 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.0 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.0 |
0.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.0 |
0.3 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.0 |
0.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.2 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.1 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.4 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 0.0 |
0.5 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.4 |
GO:0035272 |
exocrine system development(GO:0035272) |
| 0.0 |
0.4 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.0 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.2 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
0.9 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 |
0.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
0.2 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.1 |
GO:0015809 |
arginine transport(GO:0015809) |
| 0.0 |
0.5 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.2 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.0 |
0.2 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.1 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
0.0 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.0 |
0.0 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.3 |
GO:0071356 |
cellular response to tumor necrosis factor(GO:0071356) |
| 0.0 |
0.0 |
GO:0071220 |
response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
| 0.0 |
0.1 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.2 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
2.2 |
GO:0032259 |
methylation(GO:0032259) |
| 0.0 |
0.0 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.1 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.2 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.1 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.2 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.1 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.1 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.1 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
